Common genomic subtypes of human cutaneous melanoma (BRAF, RAS (N/H/K), and NF1 in 90% of cases) that engage oncogenic signaling through the MAPK pathway are less common in human non-cutaneous melanoma and in canine malignant melanoma (24% of cases here, Fig 1C). Here, NF1 is linked to melanoma.